Crysvita

Human medicines European public assessment report (EPAR): Diacomit, stiripentol, Date of authorisation: 03/01/2007, Date of refusal: 11/02/2009, Revision: 20, Status: Authorised

Herbal medicinal product: Plantaginis lanceolatae folium, Plantago lanceolata L., F: Assessment finalised

EMEA-002972-PIP02-23

EMEA-003009-PIP01-21-M01

Opinion/decision on a Paediatric investigation plan (PIP): Xevudy, sotrovimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0334/2024

Pazenir

EMEA-002818-PIP01-20-M01

Opinion/decision on a Paediatric investigation plan (PIP): Vydura, rimegepant, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0320/2024

Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0348/2024